全文获取类型
收费全文 | 331076篇 |
免费 | 20557篇 |
国内免费 | 2242篇 |
专业分类
耳鼻咽喉 | 4770篇 |
儿科学 | 10786篇 |
妇产科学 | 11058篇 |
基础医学 | 49071篇 |
口腔科学 | 8055篇 |
临床医学 | 28314篇 |
内科学 | 61946篇 |
皮肤病学 | 7094篇 |
神经病学 | 22893篇 |
特种医学 | 12799篇 |
外国民族医学 | 60篇 |
外科学 | 50214篇 |
综合类 | 12036篇 |
现状与发展 | 5篇 |
一般理论 | 165篇 |
预防医学 | 22206篇 |
眼科学 | 7734篇 |
药学 | 24473篇 |
23篇 | |
中国医学 | 2434篇 |
肿瘤学 | 17739篇 |
出版年
2021年 | 3725篇 |
2019年 | 3401篇 |
2018年 | 4884篇 |
2017年 | 3739篇 |
2016年 | 4106篇 |
2015年 | 5024篇 |
2014年 | 6458篇 |
2013年 | 9079篇 |
2012年 | 11687篇 |
2011年 | 12213篇 |
2010年 | 7900篇 |
2009年 | 6866篇 |
2008年 | 10569篇 |
2007年 | 11324篇 |
2006年 | 11200篇 |
2005年 | 10755篇 |
2004年 | 9977篇 |
2003年 | 9417篇 |
2002年 | 8840篇 |
2001年 | 14201篇 |
2000年 | 14457篇 |
1999年 | 12153篇 |
1998年 | 3479篇 |
1997年 | 3201篇 |
1996年 | 2964篇 |
1995年 | 2848篇 |
1994年 | 2616篇 |
1992年 | 8635篇 |
1991年 | 8728篇 |
1990年 | 8474篇 |
1989年 | 8245篇 |
1988年 | 7502篇 |
1987年 | 7229篇 |
1986年 | 6840篇 |
1985年 | 6629篇 |
1984年 | 4842篇 |
1983年 | 4162篇 |
1982年 | 2494篇 |
1979年 | 4457篇 |
1978年 | 3251篇 |
1977年 | 2750篇 |
1976年 | 2519篇 |
1975年 | 2851篇 |
1974年 | 3365篇 |
1973年 | 3384篇 |
1972年 | 3129篇 |
1971年 | 2955篇 |
1970年 | 2855篇 |
1969年 | 2589篇 |
1968年 | 2540篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Michels Guido Horn Rudolf Helfen Andreas Hagendorff Andreas Jung Christian Hoffmann Beatrice Jaspers Natalie Kinkel Horst Greim Clemens-Alexander Knebel Fabian Bauersachs Johann Busch Hans-Jörg Kiefl Daniel Spiel Alexander O. Marx Gernot Dietrich Christoph F. 《Der Anaesthesist》2022,71(4):307-310
Die Anaesthesiologie - 相似文献
2.
Two Janus-associated kinase inhibitors (JAKi) (initially ruxolitinib and, more recently, fedratinib) have been approved as treatment options for patients who have intermediate-risk and high-risk myelofibrosis (MF), with pivotal trials demonstrating improvements in spleen volume, disease symptoms, and quality of life. At the same time, however, clinical trial experiences with JAKi agents in MF have demonstrated a high frequency of discontinuations because of adverse events or progressive disease. In addition, overall survival benefits and clinical and molecular predictors of response have not been established in this population, for which the disease burden is high and treatment options are limited. Consistently poor outcomes have been documented after JAKi discontinuation, with survival durations after ruxolitinib ranging from 11 to 16 months across several studies. To address such a high unmet therapeutic need, various non-JAKi agents are being actively explored (in combination with ruxolitinib in first-line or salvage settings and/or as monotherapy in JAKi-pretreated patients) in phase 3 clinical trials, including pelabresib (a bromodomain and extraterminal domain inhibitor), navitoclax (a B-cell lymphoma 2/B-cell lymphoma 2-xL inhibitor), parsaclisib (a phosphoinositide 3-kinase inhibitor), navtemadlin (formerly KRT-232; a murine double-minute chromosome 2 inhibitor), and imetelstat (a telomerase inhibitor). The breadth of data expected from these trials will provide insight into the ability of non-JAKi treatments to modify the natural history of MF. 相似文献
3.
4.
5.
6.
7.
8.
9.
Hyun Jong Choi Jong Ho Moon Yun Nah Lee Hyun Su Kim Ji Su Ha Tae Hoon Lee Sang‐Woo Cha Young Deok Cho Sang‐Heum Park 《Digestive endoscopy》2015,27(7):772-775
Direct peroral cholangioscopy (POC) using an ultra‐slim upper endoscope is one modality of POC for intraductal endoscopic evaluation and treatment of the bile duct. Choledochoduodenostomy (CDS) is one modality of biliary bypass surgery that provides a new route to the bile duct. We carried out direct POC using an ultra‐slim upper endoscope without the use of accessories in 10 patients (four sump syndromes, three bile duct strictures and three intrahepatic duct stones) previously undergoing surgical CDS. Direct POC was successful in all patients. The use of an intraductal balloon catheter was required in one patient for advancement of the endoscope into the bile duct. Distal bile ducts with sump syndromes were cleared using baskets and water irrigation under direct POC. Cholangiocarcinoma was diagnosed in one patient with hilar bile duct stricture after cholangioscopic evaluation and a targeting forceps biopsy under direct POC. Intrahepatic duct stones were successfully extracted after intraductal fragmentation under direct POC. Oozing bleeding occurred during intraductal lithotripsy but stopped spontaneously. Direct POC using an ultra‐slim upper endoscope without the assistance of accessories can easily be carried out in patients undergoing CDS. 相似文献
10.
Loss‐of‐function mutations in the gene encoding filaggrin underlie a Japanese family with food‐dependent exercise‐induced anaphylaxis
下载免费PDF全文
![点击此处可从《Journal of the European Academy of Dermatology and Venereology》网站下载免费的PDF全文](/ch/ext_images/free.gif)